BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34367983)

  • 1. Protein Tyrosine Kinase 7 Regulates EGFR/Akt Signaling Pathway and Correlates With Malignant Progression in Triple-Negative Breast Cancer.
    Cui NP; Qiao S; Jiang S; Hu JL; Wang TT; Liu WW; Qin Y; Wang YN; Zheng LS; Zhang JC; Ma YP; Chen BP; Shi JH
    Front Oncol; 2021; 11():699889. PubMed ID: 34367983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamin B2 promotes the progression of triple negative breast cancer via mediating cell proliferation and apoptosis.
    Zhao CC; Chen J; Zhang LY; Liu H; Zhang CG; Liu Y
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33416073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NT5DC2 knockdown suppresses progression, glycolysis, and neuropathic pain in triple-negative breast cancer by blocking the EGFR pathway.
    Sang R; Yu X; Xia H; Qian X; Yong J; Xu Y; Sun Y; Yao Y; Zhou J; Zhuo S
    Mol Carcinog; 2024 Apr; 63(4):785-796. PubMed ID: 38289126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance and mechanism of STAT3/miR-221-3p/Fascin-1 axis in EGFR TKI resistance of triple-negative breast cancer.
    Jin LL; Lu HJ; Shao JK; Wang Y; Lu SP; Huang BF; Hu GN; Jin HC; Wang CQ
    Mol Cell Biochem; 2023 Dec; ():. PubMed ID: 38145448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell morphology best predicts tumorigenicity and metastasis in vivo across multiple TNBC cell lines of different metastatic potential.
    Conner SJ; Guarin JR; Le TT; Fatherree JP; Kelley C; Payne SL; Parker SR; Bloomer H; Zhang C; Salhany K; McGinn RA; Henrich E; Yui A; Srinivasan D; Borges H; Oudin MJ
    Breast Cancer Res; 2024 Mar; 26(1):43. PubMed ID: 38468326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SCAMP3 Regulates EGFR and Promotes Proliferation and Migration of Triple-Negative Breast Cancer Cells through the Modulation of AKT, ERK, and STAT3 Signaling Pathways.
    Acevedo-Díaz A; Morales-Cabán BM; Zayas-Santiago A; Martínez-Montemayor MM; Suárez-Arroyo IJ
    Cancers (Basel); 2022 Jun; 14(11):. PubMed ID: 35681787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DEK promoted EMT and angiogenesis through regulating PI3K/AKT/mTOR pathway in triple-negative breast cancer.
    Yang Y; Gao M; Lin Z; Chen L; Jin Y; Zhu G; Wang Y; Jin T
    Oncotarget; 2017 Nov; 8(58):98708-98722. PubMed ID: 29228721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell morphology best predicts tumorigenicity and metastasis
    Conner S; Guarin JR; Le TT; Fatherree J; Kelley C; Payne S; Salhany K; McGinn R; Henrich E; Yui A; Parker S; Srinivasan D; Bloomer H; Borges H; Oudin MJ
    bioRxiv; 2023 Jun; ():. PubMed ID: 37398306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitexin Inhibits TNBC Progression and Metastasis by Modulating Macrophage Polarization Through EGFR Signaling.
    Lin Y; Li L; Huang H; Wen X; Zhang Y; Zhang R; Huang W
    J Immunother; 2024 Jun; ():. PubMed ID: 38847148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing mebendazole against triple-negative breast cancer leptomeningeal disease.
    Rodrigues A; Chernikova SB; Wang Y; Trinh TTH; Solow-Cordero DE; Alexandrova L; Casey KM; Alli E; Aggarwal A; Quill T; Koegel A; Feldman BJ; Ford JM; Hayden-Gephart M
    Res Sq; 2024 Feb; ():. PubMed ID: 38405839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linc00707 regulates autophagy and promotes the progression of triple negative breast cancer by activation of PI3K/AKT/mTOR pathway.
    Li H; Liu Q; Hu Y; Yin C; Zhang Y; Gao P
    Cell Death Discov; 2024 Mar; 10(1):138. PubMed ID: 38485945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidating the Functional Mechanism of PTK7 in Cancer Development through Spatial Assembly Analysis Using Super Resolution Imaging.
    Qiu L; Xu H; Sui B; Jiang P; Wang J; Xu D; Liang F; Ma T; Wang H; Chen J
    Anal Chem; 2024 May; 96(19):7669-7678. PubMed ID: 38708542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-Regulation of RFC3 Promotes Triple Negative Breast Cancer Metastasis and is Associated With Poor Prognosis Via EMT.
    He ZY; Wu SG; Peng F; Zhang Q; Luo Y; Chen M; Bao Y
    Transl Oncol; 2017 Feb; 10(1):1-9. PubMed ID: 27888707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Mechanistic Investigation on the Anticancer Properties of SYA013, a Homopiperazine Analogue of Haloperidol with Activity against Triple Negative Breast Cancer Cells.
    Asong GM; Amissah F; Voshavar C; Nkembo AT; Ntantie E; Lamango NS; Ablordeppey SY
    ACS Omega; 2020 Dec; 5(51):32907-32918. PubMed ID: 33403252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TROP2 regulates cisplatin sensitivity of triple-negative breast cancer cells by regulating endoplasmic reticulum stress.
    Zhang M; Xu J; Liu Q; Yan X; Li N
    Histol Histopathol; 2024 May; ():18771. PubMed ID: 38884164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type X collagen knockdown inactivate ITGB1/PI3K/AKT to suppress chronic unpredictable mild stress-stimulated triple-negative breast cancer progression.
    Liu J; Chai XX; Qiu XR; Sun WJ; Tian YL; Guo WH; Yin DC; Zhang CY
    Int J Biol Macromol; 2024 Jun; 273(Pt 1):133074. PubMed ID: 38866293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LHPP expression in triple-negative breast cancer promotes tumor growth and metastasis by modulating the tumor microenvironment.
    Reina J; Vallmajo-Martin Q; Ning J; Michi AN; Yeung K; Wahl GM; Hunter T
    bioRxiv; 2024 Apr; ():. PubMed ID: 38712081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer.
    Giacomini A; Turati M; Grillo E; Rezzola S; Ghedini GC; Schuind AC; Foglio E; Maccarinelli F; Faletti J; Filiberti S; Chambery A; Valletta M; Melocchi L; Gofflot S; Chiavarina B; Turtoi A; Presta M; Ronca R
    Exp Hematol Oncol; 2023 Sep; 12(1):82. PubMed ID: 37749607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER3 targeting augments the efficacy of panobinostat in claudin-low triple-negative breast cancer cells.
    Lyu H; Hou D; Liu H; Ruan S; Tan C; Wu J; Hicks C; Liu B
    NPJ Precis Oncol; 2023 Aug; 7(1):72. PubMed ID: 37537339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferation and apoptosis studies of estrone pharmacophores in triple-negative breast cancer.
    Acheampong F; Ostlund T; Mahnashi M; Halaweish F
    Chem Biol Drug Des; 2023 Nov; 102(5):1050-1066. PubMed ID: 37500540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.